Skip to main content
NIH funding notice RFA-HG-23-018

Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)

Closed on March 17, 2025.

Posted
June 5, 2023
Close date
March 17, 2025
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $437,443 in first-year total cost, median $437,443.

Most frequent study sections

  1. Special Emphasis Panel[ZHG1 HGR-P (M1)]1

Most frequent institutions

  1. CASE WESTERN RESERVE UNIVERSITY1
Competing awards under RFA-HG-23-018 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2024APOL1 as a model to quantify and identify environmental modifiers of genetic associations in diverse populations1R21HG013814-01CRAWFORD, DANA CCASE WESTERN RESERVE UNIVERSITY, OH$437,443ZHG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-HG-23-018: Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional) | ScienceDex | ConductScience